QOL
Quality of Life and Outcomes
Thursday, June 2, 2022: 5:00 PM-7:00 PM
Prince George's Exhibit Hall (Gaylord National Resort & Convention Center)
Professional Skills Development Project for People with Multiple Sclerosis
Alice E Dias, Dr, Brazilian Multiple Sclerose Association (ABEM);
Gisele R Barboza, Social Worker, Brazilian Multiple Sclerose Association (ABEM);
Gecila AF Santos, Social Worker, Brazilian Multiple Sclerose Association (ABEM);
Priscila S Santos, Social Worker, Brazilian Multiple Sclerose Association (ABEM)
Severity and Progression of Fatigue Among Individuals with Multiple Sclerosis
Amber Salter, PhD, University of Texas Southwestern Medical Center;
Alexander Keenan, MA, MHP, Janssen Scientific Affairs, LLC;
Hoa H. Le, PhD, Janssen Scientific Affairs, LLC;
Kavita Gandhi, MS, Janssen Global Market Access, LLC;
Michele Cole, PharmD, MS, Janssen Pharmaceuticals;
Maria Ait-Tihyaty, PhD, Janssen Global Medical Affairs, LLC;
Samantha Lancia, MS, Washington University School in St. Louis, School of Medicine;
Robert J Fox, MD, Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic
Impact of the Interdisciplinary Team on Quality of Life in a Rural Multiple Sclerosis Clinic
Bonnie Blain, RN, CNN(C) MSCN, Red Deer Regional Hospital Centre, Alberta Health Services;
Lou-Anne Robertson, RN BScN, Central Alberta MS Clinic;
Siobhan Bast, RN BScN MSCN, Central Alberta MS Clinic;
Victoria Christiansen, BScAHN RD, Central Alberta MS Clinic;
Diana Ehlers, Data Analyst, Central Alberta MS Clinic;
Ashley A Hunter, Bachelor of Social Work, Alberta Health Services;
Cassandra Stewart, BA, MScOT, Reg. OT (AB), Central Alberta MS Clinic;
Golda Catalon, BScOT, Central Alberta MS Clinic
Relationship between Clinical Components and Demographic Variables Among Patients with Multiple Sclerosis Based on Patient Reported Outcomes
Pamela K Newland, PhD, RN, Goldfarb School of Nursing;
Ling Chen, PhD, Washington University St Louis;
Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine at Dartmouth;
Falguni Mehta, MS, MBA, Dartmouth Hitchcock Health
Confirmed Disability Improvement and Its Sustainability Among Progressive Multiple Sclerosis Patients in Clinical Trial Placebo Arms
Pengcheng Xun, PhD, Atara Biotherapeutics;
Natalia Sadetsky, MD, PhD, Atara Biotherapeutics;
Kiren Kresa-Reahl, MD, Atara Biotherapeutics;
Sasha Bogdanovich, MD, PhD, Atara Biotherapeutics;
Arie Barlev, PharmD, MS, Atara Biotherapeutics;
Crystal Watson, MS, Atara Biotherapeutics
Cognitive Impairment in People with Multiple Sclerosis: Factors That Drive Perception of Impairment Differ for Patients and Clinicians
Daija Jackson, M.A., The Chicago School of Professional Psychology;
Rachel Nicholson, M.A., Immaculata University;
Catherine S Bergmann, Psy.D., Washington Neuropsychology Research Group;
Jeffrey Wilken, PhD, Washington Neuropsychology Research Group;
Olivia Kaczmarek, BS, South Shore Neurologic Associates;
Barbara Bumstead, MS, ANP-C, MSCN, South Shore Neurologic Associates;
Marijean Buhse, NP-C, PhD, South Shore Neurologic Associates, P.C.;
Myassar Zarif, MD, South Shore Neurologic Associates, P.C.;
Mark Gudesblatt, MD, South Shore Neurologic Associates, P.C.
Effects of a Weight Based Training Program on Bone Density, Cognition, and Quality of Life
Dana Jones, NP, Holy Name Medical Center;
Anthony M Iuso, DO, Holy Name Medical Center;
Joseph Sarni, n/a, n/a;
Karen Blitz, DO, South Shore Neurologic Associates;
Frederick W Foley, Ph.D., Yeshiva University;
Mary Ann Picone, MD, Holy Name Medical Center
Perceptions of Multiple Sclerosis Care during the COVID-19 Pandemic: Examining Real-World Evidence from Patients and Providers
Derrick S Robertson, MD, Multiple Sclerosis Division, Department of Neurology, University of South Florida;
Gabriel Pardo, MD, FAAN, Oklahoma Medical Research Foundation;
Mitzi J Williams, MD, Joi Life Wellness, MS Neurology Center;
Joseph R Berger, MD, FACP, FAAN, FANA, Perelman School of Medicine, University of Pennsylvania;
David Meyer, MD, MBA, Wake Forest Baptist Health;
Daniel S Bandari, MD, MS, Multiple Sclerosis Center of California and Research Group;
Harold Moses, MD, Vanderbilt University Medical Center;
Fernando X Cuascut, MD, MPH, Baylor College of Medicine;
Alexis Jameson, BA, PRIME Education;
Jeffrey Carter, PhD, PRIME Education;
Laura Simone, PhD, PRIME Education;
Larissa Jarzylo, PhD, PRIME Education
College Students and Multiple Sclerosis: Developing a Toolkit for Academic Success
Annalise Lowy, PT/s, Massachusetts College of Pharmacy and Health Sciences;
Andrew Faria, PT/s, Massachusetts College of Pharmacy and Health Sciences;
Kirsten Sjogren, PT/s, Massachusetts College of Pharmacy and Health Sciences;
Cameron Watson, PT/s, Massachusetts College of Pharmacy and Health Sciences;
Erin M Faraclas, PT, DPT, PhD, MSCS, Massachusetts College of Pharmacy and Health Sciences
The Relationship between Vascular Comorbidities and Physical Activity in Persons with Multiple Sclerosis
Heather M DelMastro, MS, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Frank H. Netter MD School of Medicine at Quinnipiac University;
Jennifer A Ruiz, DPT, Frank H. Netter MD School of Medicine at Quinnipiac University, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England;
Lindsay O Neto, MPH, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Frank H. Netter MD School of Medicine at Quinnipiac University
Differences in Work, Active Transportation, Domestic and Garden, and Leisure Domains of Physical Activity By Disability Level in Multiple Sclerosis
Heather M DelMastro, MS, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Frank H. Netter MD School of Medicine at Quinnipiac University;
Elizabeth S Gromisch, PhD, MSCS, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, University of Connecticut School of Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University;
Lindsay O Neto, MPH, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Frank H. Netter MD School of Medicine at Quinnipiac University;
Jennifer A Ruiz, DPT, Frank H. Netter MD School of Medicine at Quinnipiac University, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England
Quality of Life and Treatment Outcomes Among People with Multiple Sclerosis before and during the COVID-19 Pandemic
Jacqueline A Nicholas, MD, MPH, OhioHealth Multiple Sclerosis Center;
deMauri S Mackie, PhD, Cerner Enviza;
Halley Costantino, MS, Cerner Enviza;
Lori A Lebson, PhD, EMD Serono;
Emily Mulvihill, BS, MBA, Cerner Enviza;
Amy L Phillips, PharmD, EMD Serono
Work Productivity Among People with Multiple Sclerosis before and during the COVID-19 Pandemic
Jacqueline A Nicholas, MD, MPH, OhioHealth Multiple Sclerosis Center;
deMauri S Mackie, PhD, Cerner Enviza;
Halley Costantino, MS, Cerner Enviza;
Lori A Lebson, PhD, EMD Serono;
Emily Mulvihill, BS, MBA, Cerner Enviza;
Amy L Phillips, PharmD, EMD Serono
Restless Leg Syndrome in Individuals with Multiple Sclerosis: Effects on Disability and Perceived Physical Health
Nidhila Masha, B.S., Duke University School of Medicine;
Simon Gregory, PhD, Duke University;
James Giarraputo, B.S., Duke University School of Medicine;
Farren B.S. Briggs, PhD, ScM, Case Western Reserve University School of Medicine;
Sabrina Cote, PhD, N/A;
Suma Shah, MD, Duke University
Patient-Reported Outcomes for Patients Treated with Peginterferon Beta-1a: Plegridy Observational Program Interim Analysis
Sibyl Wray, MD, Hope Neurology MS Center;
Marco Salvetti, MD, Sapienza University, S. Andrea Hospital;
Gereon Nelles, MD, Neurology, NeuroMed Campus Hohenlind;
Nydjie Grimes, MPH, BA, Biogen, at the time of this analysis;
Nicholas Belviso, PhD, Biogen;
Thijs Koster, MSc, Biogen
Impact of Cognitive Impairment on Quality of Life and Work Productivity of Relapsing-Remitting Multiple Sclerosis Patients: A Systematic Literature Review
Lea Achrafie, MS, Amaris Consulting;
Joelle Constantin, MS, Amaris Consulting;
Maud Pacou, MS, Amaris Consulting;
Jinender Kumar, MS, Bristol Myers Squibb;
Tom Tencer, PhD, Bristol Myers Squibb
Multiple Sclerosis Patients Have Higher Full Employment Rates Than Other Patients Following in the Neuroimmunology Clinic.
Delaney Cairns, BS, Medical College of Wisconsin;
Mokshal H Porwal, BSc, Medical College of Wisconsin;
Amber Salter, PhD, University of Texas Southwestern Medical Center;
Samantha O'Dell, BA, Medical College of Wisconsin;
DeAnna Finnessy, MA, Medical College of Wisconsin;
Camila Ishueva, BS, Medical College of Wisconsin;
Murali Palathinkara, BS, Medical College of Wisconsin;
Abrahim N Razzak, BS, Medical College of Wisconsin;
Ahmed Z Obeidat, MD, Ph.D., Medical College of Wisconsin
